Inhibitors of phosphatases

Details for Australian Patent Application No. 2003300114 (hide)

Owner Vertex Pharmaceuticals Incorporated

Inventors Blake, James F.; Vigers, Guy P. A.; Saunders, Jeffrey O.; Buckmelter, Alexandre J.; Hunt, Kevin W.; Sun, Xicheng; Miknis, Gregory F.

Agent Cullen & Co

Pub. Number AU-B-2003300114

PCT Number PCT/US2003/0416

PCT Pub. Number WO2004/060878

Priority 60/437,576 31.12.02 US

Filing date 31 December 2003

Wipo publication date 29 July 2004

Acceptance publication date 23 July 2009

International Classifications

A61K 9/00 (2006.01) Medicinal preparations characterised by special physical form

A61K 9/24 (2006.01) Medicinal preparations characterised by special physical form - Layered or laminated unitary dosage forms

A61K 9/28 (2006.01) Medicinal preparations characterised by special physical form - Dragees

A61K 31/58 (2006.01) - containing heterocyclic rings, e.g. aldosterone, danazol, stanozolol, pancuronium, digitogenin

A61K 31/7072 (2006.01)

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

Event Publications

27 May 2004 Complete Application Filed

  Priority application(s): 60/437,576 31.12.02 US

2 September 2004 Application Open to Public Inspection

  Published as AU-B-2003300114

23 July 2009 Application Accepted

  Published as AU-B-2003300114

19 November 2009 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003300115-Liquid applicator with a mechanism for fracturing multiple ampoules

2003300113-Topical stabilized prostaglandin E compound dosage forms